Susanne Fischer1, Johanna M Doerr1, Jana Strahler1, Ricarda Mewes2, Kati Thieme3, Urs M Nater4. 1. Clinical Biopsychology, Department of Psychology, University of Marburg, Germany. 2. Clinical Psychology and Psychotherapy, Department of Psychology, University of Marburg, Germany. 3. Department for Medical Psychology, Medical School, University of Marburg, Germany. 4. Clinical Biopsychology, Department of Psychology, University of Marburg, Germany. Electronic address: nater@uni-marburg.de.
Abstract
OBJECTIVE: Although fibromyalgia syndrome (FMS) is a chronic condition, its cardinal symptom pain is known to fluctuate over the day. Stress has often been claimed to exacerbate pain; however, there is barely any evidence on whether or not this is true on a day-to-day basis (and, alternatively, on whether pain leads to increased stress levels). Using an ecologically valid measurement design, we tested whether and how stress and pain are intertwined in participants with FMS. We additionally examined the role of the two major stress-responsive systems, the hypothalamic-pituitary-adrenal axis and the autonomic nervous system, as potential mediators of this relationship. METHODS: An ambulatory assessment study was conducted over the course of 14 days. On each day, 32 females with FMS provided six diary entries on momentary stress and pain levels. Saliva samples were collected at the same time points to determine cortisol and alpha-amylase as indicators of stress-responsive systems. RESULTS: Higher stress at a given measurement time point was associated with higher reported pain levels at the subsequent time point (UC=1.47, p<0.001), but not vice versa (UC<0.01, p=0.179). The stress-pain relationship was neither mediated by momentary cortisol nor by alpha-amylase; however, momentary cortisol was independently associated with momentary pain (UC=0.27, p=0.009). CONCLUSION: Stress seems to be a powerful exacerbating factor for pain as experienced by patients with FMS in their everyday lives. Cortisol may be involved in the diurnal fluctuation of pain levels in patients with FMS. Future studies should identify relevant daily stressors in persons with FMS and scrutinize the mechanisms underlying the cortisol-pain relationship.
OBJECTIVE: Although fibromyalgia syndrome (FMS) is a chronic condition, its cardinal symptom pain is known to fluctuate over the day. Stress has often been claimed to exacerbate pain; however, there is barely any evidence on whether or not this is true on a day-to-day basis (and, alternatively, on whether pain leads to increased stress levels). Using an ecologically valid measurement design, we tested whether and how stress and pain are intertwined in participants with FMS. We additionally examined the role of the two major stress-responsive systems, the hypothalamic-pituitary-adrenal axis and the autonomic nervous system, as potential mediators of this relationship. METHODS: An ambulatory assessment study was conducted over the course of 14 days. On each day, 32 females with FMS provided six diary entries on momentary stress and pain levels. Saliva samples were collected at the same time points to determine cortisol and alpha-amylase as indicators of stress-responsive systems. RESULTS: Higher stress at a given measurement time point was associated with higher reported pain levels at the subsequent time point (UC=1.47, p<0.001), but not vice versa (UC<0.01, p=0.179). The stress-pain relationship was neither mediated by momentary cortisol nor by alpha-amylase; however, momentary cortisol was independently associated with momentary pain (UC=0.27, p=0.009). CONCLUSION: Stress seems to be a powerful exacerbating factor for pain as experienced by patients with FMS in their everyday lives. Cortisol may be involved in the diurnal fluctuation of pain levels in patients with FMS. Future studies should identify relevant daily stressors in persons with FMS and scrutinize the mechanisms underlying the cortisol-pain relationship.
Authors: José V Pardo; Robert C Larson; Rachel J Spencer; Joel T Lee; Jeffrey D Pasley; Carolyn J Torkelson; Alice A Larson Journal: Clin J Pain Date: 2019-05 Impact factor: 3.442
Authors: Ariel B Neikrug; Gary Donaldson; Eli Iacob; Sam L Williams; Christopher A Hamilton; Akiko Okifuji Journal: Pain Date: 2017-08 Impact factor: 6.961
Authors: Irene Tsilioni; Irwin J Russell; Julia M Stewart; Rae M Gleason; Theoharis C Theoharides Journal: J Pharmacol Exp Ther Date: 2016-01-13 Impact factor: 4.030
Authors: Inge Timmers; Conny W E M Quaedflieg; Connie Hsu; Lauren C Heathcote; Cynthia R Rovnaghi; Laura E Simons Journal: Neurosci Biobehav Rev Date: 2019-10-14 Impact factor: 8.989